Health and doping in elite-level cycling

Scandinavian Journal of Medicine and Science in Sports

Volumn 22, Issue 5, 2012, Pages 596-606

  Lentillon Kaestner, V ^a   Hagger, M S ^b   Hardcastle, S ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Amateur level; Cycling; Doping behaviors; Health risks; Performance enhancing drugs; Professional level; Sport

Indexed keywords

PERFORMANCE ENHANCING SUBSTANCE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BICYCLE; COMPETITIVE BEHAVIOR; DOPING; HEALTH STATUS; HUMAN; MALE; PHYSIOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SAFETY; SWITZERLAND;

BICYCLING; COMPETITIVE BEHAVIOR; DOPING IN SPORTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; PERFORMANCE-ENHANCING SUBSTANCES; QUALITATIVE RESEARCH; SAFETY; SWITZERLAND; YOUNG ADULT;

EID: 79960084421     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2010.01281.x     Document Type: Article

References (40)

1. Arditti J, Bourdon J-H, De Haro L, Obelia E, Valli M. Le cadre, les médicaments et les substances de la performance. Ann de Toxicol Anal 2000: 12: 26-29.
2. Bassons C, ed. Positif. Paris: Stock, 2000.
3. Black T. Does the ban on drugs in sport improve societal welfare. Int Rev Soc Sport 1996: 31: 367-381.
4. Brissonneau C, Bui-Xuan-Picchedda K. Analyse psychologique et sociologique du dopage. Rationalisation du discours, du mode de vie et de l'entraînement sportif. Rev Staps 2005: 70: 59-73.
5. Brissonneau C, Defrance J, Fincoeur B, Lentillon-Kaestner V, Ohl F. Carrière sportive et socialisation secondaire en cyclisme sur route: les cas de la Belgique, la France et la Suisse. Rapport de fin de recherche financée par l'Agence Mondiale Antidopage (AMA). Lausanne, Suisse, 2009.
6. Carpenter PC. Performance-enhancing drugs in sport. Endocrinol MetabClin N Am 2007: 36: 481-495.
7. De Mondenard J-P. Dictionnaire du dopage. Paris: Masson, 2004.
8. Duclos M, Guinot M, Colsy M, Merle F, Baudot C, Corcuff JB, Lebouc Y. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc 2007: 39: 1036-1043.
9. Fotheringham W. Hard ride to redemption for one man and his sport. The Observer. Available at http://www.guardian.co.uk/sport/2008/jun/2029/tourdefrance.cycling2001 (accessed on June 29, 2008).
10. Girandola F. Psychologie de la persuasion et de l'engagement. Presses Universitaires de Franche-Comté, 2003.
11. Goldman B, Klatz R. Death in the Locker Room II. Chicago, IL: Elite Sports Medicine Publications Inc., 1992.
12. Hagger MS. Self-regulation: an important construct in health psychology research and practice. Health Psychol Rev 2010: 4: 57-65.
13. Hagger MS, Chatzisarantis NLD. Integrating the theory of planned behaviour and self-determination theory in health behaviour: a meta-analysis. Br J Health Psychol 2009: 14: 275-302.
14. Hidalgo I, Garrigo G, Hernandez M. Health status and risk behavior of adolescents in the north of Madrid, Spain. J Adolesc Health 2000: 27: 351-360.
15. Hoberman J. Testosterone dreams: Rejuvenation, aphrodisia, doping. Los Angeles: University of California Press, 2005.
16. Holm S. Doping under medical control - conceptually possible but impossible in the world of professional sports? Sport, Ethics Philos 2007: 1: 135-145.
17. Jones C. Doping in cycling: realism, antirealism and ethical deliberation. J Philos Sport 2010: 37: 88-101.
18. Kayser B, Smith AC. Globalisation of anti-doping: the reverse side of the medal. BMJ 2008: 337: 85-87.
19. Kimmage P, ed. Rough ride: behind the wheel with a pro cyclist. London, UK: Random House, 2001.
20. Kindlundh A, Isacson D, Berglund L, Nyberg F. Doping among high school students in Uppsala, Sweden: a presentation of the attitudes, distinction, side effects, and extent of use. Scand J Soc Med 1998: 26: 71-74.
21. König E. Criticism of doping: the nihilistic side of technological sport and the antiquated view of sport ethics. Int Rev Soc Sport 1995: 30: 247-260.
22. Laure P. Dopage et société. Paris: Ellipses, 2000.
23. Laure P, Lecerf T. Prévention du dopage sportif chez les adolescents: à propos d'une action évaluée d'éducation pour la santé. Arch Pédriatr 1999: 6: 849-854.
24. Laure P, Lecerf T, Le Scanff C. Les motivations à la consommation de produits dangereux sont-elles liées au nombre de substances utilisées? Enquête auprès de 840 adolescents scolarisés. Arch Pédriatr 2001: 8: 16-24.
25. Lê-Germain E, Leca R. Les conduites dopantes fondatrices d'une sous culture cycliste (1965-1999). Rev Staps 2005: 70: 109-132.
26. Lentillon-Kaestner V. Conduites dopantes chez les jeunes cyclistes du milieu amateur au milieu professionnel. Psychotropes 2008: 14: 41-57.
27. Lentillon-Kaestner V, Brissonneau C. Appropriation progressive de la culture du dopage dans le cyclisme. Déviance et Société 2009: 33: 519-541.
28. Lentillon-Kaestner V, Carstairs C. Doping use among young elite cyclists: a qualitative psychosociological approach. Scand J Med Sci Sports 2010: 20: 336-345.
29. Leventhal H, Meyer D, Nerenz D. The common sense model of illness danger. In: Rachman S, ed. Medical psychology. New York: Pergamon Press 1980: 7-30.
30. Mucchielli R. L'analyse de contenu: des documents et des communications. Paris: Edition ESF, 1998.
31. Papadopoulos FC, Skalkidis I, Pakkari J, Petridou E. Doping use among tertiary education students in six developed countries. Eur J Epidemiol 2006: 21: 307-313.
32. Pipe A, Ayotte C. Nutritional supplements and doping. Clin J Sport Med 2002: 12: 245-249.
33. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo J, Petty R, eds. Social psychophysiology. New York: Guilford Press, 1983.
34. Schneider AJ. Cultural nuances: doping, cycling and the tour de France. Sport Soc 2006: 9: 212-226.
35. Stewart PS, Smith BE, Atav AS, Britten MX, Collins MS, Lake Morgan LC, Spencer GA. Integrative research review of risk behaviors among adolescents in rural, suburban, and urban areas. J Adolesc Health 1999: 24: 230-243.
36. Tanner JF, Hunt JB, Eppright DR. The protection motivation model: a normative model of fear appeals. J Mark 1991: 55: 36-45.
37. Voet W. Massacre à la chaîne: révélations sur 30 ans de tricheries. Paris: Calmann-Lévy, 1999.
38. WADA. The World Antidoping Code: the 2009 prohibited list - International standard. 2009. Available at http://www.wada-ama.org/ (accessed August 1, 2010).
39. Waddington I. Sport, health and drugs. A sociological perspective. London: E. & F.N. Spon, 2000.
40. Witte K., Allen M.A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav 2000: 27(5): 591-615.